HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas A Ciulla Selected Research

bevasiranib

5/2009Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas A Ciulla Research Topics

Disease

30Macular Degeneration (Age-Related Maculopathy)
09/2023 - 02/2002
23Macular Edema
01/2024 - 09/2003
11Choroidal Neovascularization
01/2022 - 12/2003
7Uveitis
01/2024 - 06/2004
7Diabetic Retinopathy (Retinopathy, Diabetic)
02/2023 - 09/2003
7Retinal Diseases
01/2022 - 06/2004
7Inflammation (Inflammations)
03/2020 - 06/2004
6Retinal Vein Occlusion
12/2022 - 05/2009
5Geographic Atrophy
09/2023 - 10/2017
4Choroidal Effusions
03/2024 - 01/2020
4Eye Diseases (Eye Disease)
07/2023 - 12/2003
4Wounds and Injuries (Trauma)
12/2005 - 12/2003
3Hemorrhage
04/2006 - 12/2002
2Glaucoma
12/2022 - 05/2018
2Night Blindness (Nyctalopia)
10/2018 - 01/2018
2Epiretinal Membrane (Epiretinal Membranes)
10/2018 - 07/2005
2Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2018 - 05/2003
2Leber Congenital Amaurosis
01/2018 - 05/2003
2Edema (Dropsy)
11/2010 - 12/2004
2Endophthalmitis (Ophthalmia)
11/2006 - 01/2002
2Cataract (Cataracts)
10/2004 - 01/2002
1Tics (Tic)
12/2022
1Wet Macular Degeneration
01/2022
1Ocular Hypertension (Glaucoma, Suspect)
05/2018
1Optic Nerve Diseases (Optic Neuropathy)
05/2018
1Histoplasmosis
11/2009
1Myocardial Infarction
11/2006
1Stroke (Strokes)
11/2006
1Retinal Perforations
07/2005

Drug/Important Bio-Agent (IBA)

18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 12/2004
11Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2024 - 01/2007
8Retinaldehyde (Retinal)IBA
03/2024 - 02/2002
8SuspensionsIBA
01/2024 - 01/2020
7Bevacizumab (Avastin)FDA Link
11/2018 - 05/2009
7Ranibizumab (Lucentis)FDA Link
01/2017 - 04/2006
6Adrenal Cortex Hormones (Corticosteroids)IBA
10/2023 - 06/2004
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017 - 06/2004
3Complement System Proteins (Complement)IBA
09/2023 - 10/2017
3Biomarkers (Surrogate Marker)IBA
02/2023 - 01/2022
3afliberceptIBA
01/2021 - 05/2009
3Triamcinolone (Aristocort)FDA Link
11/2018 - 03/2010
3Dexamethasone (Maxidex)FDA LinkGeneric
11/2018 - 09/2013
3Endothelial Growth FactorsIBA
05/2018 - 12/2004
31-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2006 - 08/2004
2SteroidsIBA
10/2023 - 06/2004
2Fluocinolone Acetonide (Capex)FDA LinkGeneric
10/2023 - 05/2014
2salicylhydroxamic acid (SHAM)IBA
02/2023 - 12/2002
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 01/2021
2emixustatIBA
10/2018 - 01/2018
2Vitamin A (Retinol)FDA LinkGeneric
10/2018 - 01/2018
2FenretinideIBA
10/2018 - 01/2018
2CytokinesIBA
01/2017 - 06/2004
2Photosensitizing Agents (Photosensitizers)IBA
06/2005 - 08/2004
2Protein Kinase CIBA
05/2005 - 12/2004
1pegcetacoplanIBA
09/2023
1AcidsIBA
12/2022
1Bimatoprost (Lumigan)FDA Link
12/2022
1Latanoprost (Xalatan)FDA Link
12/2022
1Immunologic Factors (Immunomodulators)IBA
08/2022
1Vascular Endothelial Growth Factor CIBA
01/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022
1IntegrinsIBA
01/2022
1Vascular Endothelial Growth Factor DIBA
01/2022
1acrizanibIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Axitinib (AG 013736)IBA
01/2021
1Plasma KallikreinIBA
03/2020
1AngiopoietinsIBA
10/2019
1AKB-9778IBA
10/2019
1lampalizumabIBA
01/2019
1Complement Factor D (Factor D)IBA
01/2019
1Complement C5 (Complement 5)IBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2017
1Platelet-Derived Growth FactorIBA
01/2017
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2017
1GlucocorticoidsIBA
05/2014
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
05/2010
1bevasiranibIBA
05/2009
1pegaptanib (Macugen)FDA Link
05/2009
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2007
1Verteporfin (Visudyne)FDA Link
11/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2005
1lumiracoxib (prexige)IBA
12/2005
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2005
1Linezolid (Zyvox)FDA Link
07/2005
1TabletsIBA
07/2005
1Aldehyde Reductase (Aldose Reductase)IBA
05/2005
1Oxygen (Dioxygen)IBA
05/2005
1AntioxidantsIBA
05/2005

Therapy/Procedure

25Therapeutics
10/2023 - 10/2002
12Lasers (Laser)
11/2018 - 12/2003
6Injections
01/2024 - 01/2007
6Light Coagulation
07/2023 - 05/2003
5Drug Therapy (Chemotherapy)
07/2023 - 12/2004
5Photochemotherapy (Photodynamic Therapy)
11/2006 - 07/2002
3Intravitreal Injections
05/2018 - 04/2006
2Intraocular Injections
01/2020 - 11/2010
2Vitrectomy
07/2005 - 03/2002
1Investigational Therapies (Experimental Therapy)
10/2019
1Oral Administration
12/2005